The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Good day of consolidation, with people buying in for longer than 1 day hopefully... If the next RNS brings more positive news then we should be in business. In the meantime, hopefully the price will remain stable
Completely agree Chickndinner, I was aware of SKIN before yesterday and had done some research, so had no doubts about going in heavily from the bell. It was tricky to buy, but I’m happy with holding this morning!
It won’t reach 2.5p for a little while yet but if this turnaround continues or accelerates then it’s not hard to imagine this reaching 10m mcap, which would be 2.7p...
Starting to move now; 0.49 to but and sell... What particularly impressed me was the Stoer Skincare range - stocked in Harvey Nics and has won awards etc. So much value at this price level!
Any RNS that includes the word transformational is worth a second read - this is a ten bagger just to get back to it’s IPO price! Based on today’s news, it’s got to have a chance of achieving it!
Nice to see those big sells cleared, also positive to see the ask rising into the close. All in all a much better day, hopefully continue the recovery tomorrow & setup well for a Friday rally!
I feel as this sell of has been accentuated by the following factors; Short term traders buying in the 4/5’s and then selling out Regular punters being scared out by the volatility, which has been extreme A large holder reducing their holding The fact is this share has very low free float and when it turns it will be rapid. I’m happy that DS did the Vox podcast as for me it shows he is engaged and working on contracts, radio silence would be much worse. Also agree with the post below, if there was news due he wouldn’t exactly announce it to Justin! Overall I feel this has to be close to the bottom, momentum will turn and we’ll head back towards 5p. This share has always been volatile, the swing higher has just increased the range of volatility & combined with MM’s taking the **** with the spread, has resulted in many losing their nerve. If this was genuine game changing news around the corner, surely this is exactly what they want; scare out short termers and make as many as possible buy in once news is out...
Interesting to note that the total of the huge trade on 8/11 (4.5m) that looked like a rollover trade is so close to the total of the 4 large sells this afternoon (4.6m). Could be a coincidence, we’ll know tomorrow if there are any more large sells!
Completely agree Vitali, 5.4 billion views for October is spectacular! If it is Invesco selling, I wonder if it’s to provide market makers with some ammunition before the announcement... it would be first time they’ve offloaded without news. Topped up at 1.39, huge upside from here particularly as we know they have nailed October!
Yuyus, please explain how lots of innocent holders lost our today? If you were a holder like me it was a very exciting day, albeit bizarre. Only those who foolishly set stop losses on a very volatile share, or buy on a spike and the sell as soon as it drops again have lost out? Did you get caught on the spike by any chance?
Yuyus, you seem far more obsessed with the ravings of a few lunatics on twitter than anyone else on this board? Funnily enough, the world doesn’t revolve around twitter and the majority of sane, serious investors won’t chuck in money without doing research and observing the SP for a while. A lot of people are clearly interested in this share, and who’d have thought it given it’s in the life insurance sector... if you bother to research it this weekend (read the admission document, all RNS’s and listen to the podcast from May on Vox) you may realise that this is much more than a pump and dump story driven by twitter. We have a quality team, regulated product, are fully funded with a small free float and potential news overdue. What’s not to like...
Annualised production should be 3750T, which is 937T per quarter. YTD Bushveld have produced 1897T and now guidance has been downgraded again to 2600-2650, suggesting Q4 production in the range of 703-753T. if the strike etc has been resolved, why is Q4 going to miss the annualised target by a minimum of 184 - 234T or 20-30% ? I feel as though the issues raised in the Q2 report regarding declining grades etc have continued to impact production, but this time have been deliberately overlooked in the RNS, because the strike action provides a convenient excuse? In addition, it potentially adds insight into why Sojitz were happy to take £20m for their stake of Vametco if grades are declining. The cash flow in undoubtedly strong and will be exceptional for Q4, but regardless the declining production relative to 2017 has to be seen as a missed opportunity in my eyes.
Until the review is finished and they have a meaningful update I’m really not sure what you expect the CEO to tell you? Fact is that anyone who bought in after the initial RNS shocker two weeks ago could have booked 100% profit this time last week. Given the accounting issues and the fact the entire business model is now up in the air, expecting £3+ in the short term was never realistic. If the review comes back relatively clean with no further problems (hardly a given) and they confirm that 2019 will return to profit, then a real recovery could begin. Until that point holding is fraught with risk IMO.
I’m also a happy investor, and having done some more digging on the company last night I’m ever happier. All directors have healthy stakes & whilst the exact free float is difficult to determine, from looking at the recently posted confirmation statement on companies house there are a significant number of large private shareholders from the IPO placing who haven’t sold any shares @ 30th September. Real free float could be as low as 30m shares, which would explain the erratic price behaviour. However, the undoubted trend is up. There is also some interesting block buying going on, every day this week there has been between 1-5 trades for £4967, which to me does suggest an international buyer taking £5k chunks less dealing costs... I find it hard to believe that we won’t get a positive RNS this side of Christmas, that’s only 31.5 trading days and the impact could be spectacular to say the least.
Good call Babbler, I sold at 1.81 yesterday and am a bit ****ed off this morning but made a decent profit! Thing is, any hint of bad news when they next update us and it’ll drop right back down - as the price rises beyond 2.30 so the risk increases too...
PMatlock is definitely on the wind up. Firstly, even after the recent sharp fall VRS has still 8 bagged in a year, how is that ending in tears? However, it is still loss making unlike our company. If we hit 200m mcap within a year there will be nothing but joy, I feel anything is possible with our rate of expansion & CEO’s global contact book.